Historical record - last NADAC publication: 4/20/2022
Product Information
TOPIRAMATE 100 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0651 per EA under NDC 69097081815. Its NADAC has been published 284 times since Nov 23, 2016.
Strength
100 mg/1
Manufacturer
Cipla USA Inc.NDC
69097081815
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/20/2022
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA079162On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 100 MG TABLET has been published 284 times since Nov 23, 2016, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0651 per EA |
|---|---|
| All-time high | $0.0823 (Nov 13, 2019) |
| All-time low | $0.0570 (Jan 23, 2019) |
| Median price | $0.0705 |
| Average price | $0.0705 |
| Largest weekly change | +17.7% (Feb 20, 2019) |
| Weeks tracked | 284 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 100 MG TABLET, manufactured by Cipla USA Inc., is $0.0651 per EA (NDC 69097081815), effective Apr 27, 2022.
How has the price of TOPIRAMATE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 100 MG TABLET has declined 11.7%. It has been tracked across 284 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 100 MG TABLET?
Since Nov 23, 2016, the NADAC for TOPIRAMATE 100 MG TABLET has ranged from a low of $0.0570 (Jan 23, 2019) to a high of $0.0823 (Nov 13, 2019), with a median of $0.0705 per EA.
Are there cheaper alternatives to TOPIRAMATE 100 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 100 MG TABLET, is $0.0559 per EA — about 14% below TOPIRAMATE 100 MG TABLET.
Who manufactures TOPIRAMATE 100 MG TABLET?
TOPIRAMATE 100 MG TABLET (NDC 69097081815) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification